连续性血液净化在脓毒血症治疗中作用
摘要
关键词
全文:
PDF参考
黄观日,陆俊江,王昌伟,等.连续性血液净化在治疗重症脓毒血症中的临床效果[J].吉林医学,2022,43(12):3322-3324.
WESTERMANN, ISABELLA, GASTINE, et al. Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis [J]. British Joumal of Clinical Pharm acology,2021,87(11):4293-4303.
Arora J, Mendelson AA, Fox-Robichaud A. Sepsis: net-work pathophysiology and implications for early diag-nosis[J]. Am J Physiol Regul Integr Comp Physiolm,2023,324(5):R613-R624.
宋小炜,张凌.高截留滤器一连续性肾脏替代治疗在脓毒血症合并急性肾损伤中的应用进展[J].中国血液净化,2022,21(2):81-84.
刘建林.连续性血液净化治疗重症脓毒血症的疗效及对血清TNF-α、IL-10水平的影响[J].临床医学,2022,42(6):42-43.
汪媛,雷建卫,宣向飞.CRRT联合血液灌流治疗对脓毒血症合并多器官功能衰竭患者预后的影响[J].检验医学与临床,2021,18(5):679-681.
马冠华,李向阳,周伊南,等.连续性肾脏替代治疗在治疗高龄脓毒症合并急性肾损伤患者的作用[J].中国呼吸与危重监护杂志,2020,19(5):463-466.
刘道勤,赵洪静,周茹,等.巨噬细胞移动抑制因子对脓毒血症急性肾损伤和不良预后预测价值的研究[J].临床肾脏病杂志,2023,23(3):221-227.
刘紫晨.血液灌流联合连续性血液净化在重症脓毒血症治疗中的应用价值[J].中外女性健康研究,2022,6(7):118-119+178.
刘嵩.不同剂量血液滤过对脓毒血症患者肾功能炎症反应疾病程度及治疗转归的影响[J].山西医药杂志,2022,51(4):385-389.
KAYA U B,CICEK H,KUL S,et al. Effect of a novel extracorporeal cytokine apheresis method on endocan,copeptin and interleukin-6 levels in sepsis:an observational prospective study [J]. Transfus Apher Sci,2020,59(6):102919.
HAWCHAR F, RAO C, AKIL A, et al. The potential role of extracorporeal cytokine removal in hemodynamic stabilization in hyperinflammatory shock[J]. Biomedicines,2021,9(7):456.
WELBORN M B, OLDENBURG H S, HESS P J, et al. The relationship between visceral ischemia,proinflammatory cytokines,and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair[J]. Crit Care Med,2000,28(9):3191-3197.
ZHANG L, COVE M, NGUYEN B G, et al. Adsorptive hemofiltration for sepsis management[J]. Chin Med J(Engl),2021,134(18):2258-2260.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i8.20499
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。